Related Experiment Video
Updated: Feb 1, 2026

Reconstitution Of β-catenin Degradation In Xenopus Egg Extract
Published on: June 17, 2014
Long non-coding RNA Linc00320 inhibits glioma cell proliferation through restraining Wnt/β-catenin signaling
Shuaiwei Tian1, Wei Liu2, Yixin Pan2
1Department of Pediatric Neurosurgery, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, No.639 Zhizaoju Road, Shanghai 200011, China.
Abstract:
Recent efforts have revealed that numerous oncogenic lncRNAs have been found play pivotal role in Glioma progression while there is little know about anti-oncogenic lncRNAs in Glioma. In current study, we found a HMGB1 regulated lncRNA, Linc00320, is significantly decreased in Glioma malignant tissues and its low expression predicts poor prognosis. Moreover, we found that the nucleus localized Linc00320 inhibits Glioma cell proliferation both in vitro and in vivo. In addition, we found that Linc00320 binds to β-catenin and inhibits the activity of Wnt/β-catenin signaling by disrupting β-catenin binds to TCF4 in Glioma cells. Taken together, we firstly demonstrated the tumor suppressive lncRNA, Linc00320, is down-regulated in Glioma tissues and inhibits Glioma cell proliferation by restraining Wnt/β-catenin signaling through segregating β-catenin and TCF4 and revealed the novel HMGB1/Linc00320/β-catenin axis in Glioma progression.
Insights
This study identifies Linc00320 as a tumor-suppressive long noncoding RNA (lncRNA) in Glioma. Its decreased expression inhibits Glioma cell proliferation by targeting the Wnt/β-catenin signaling pathway.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Numerous oncogenic long noncoding RNAs (lncRNAs) are implicated in Glioma progression.
- The role of anti-oncogenic lncRNAs in Glioma remains largely unexplored.
Purpose of the Study:
- To investigate the function of the HMGB1-regulated lncRNA, Linc00320, in Glioma.
- To elucidate the mechanism by which Linc00320 affects Glioma cell proliferation and signaling pathways.
Main Methods:
- Analysis of Linc00320 expression in Glioma tissues.
- In vitro and in vivo studies to assess the effect of Linc00320 on Glioma cell proliferation.
- Investigation of Linc00320's interaction with β-catenin and its impact on Wnt/β-catenin signaling.
Main Results:
- Linc00320 expression is significantly decreased in Glioma tissues, correlating with poor prognosis.
- Nuclear-localized Linc00320 inhibits Glioma cell proliferation both in vitro and in vivo.
- Linc00320 binds to β-catenin, disrupting the β-catenin/TCF4 complex and inhibiting Wnt/β-catenin signaling.
Conclusions:
- Linc00320 acts as a tumor suppressor in Glioma by inhibiting cell proliferation.
- The HMGB1/Linc00320/β-catenin axis represents a novel regulatory pathway in Glioma progression.
- Down-regulation of Linc00320 contributes to Glioma malignancy, suggesting its potential as a therapeutic target.
Related Concept Videos
Canonical Wnt Signaling Pathway
Non-Canonical Wnt Signaling Pathways
lncRNA - Long Non-coding RNAs
Catenins
Catenins in Cell Junctions
Catenins bind to cell adhesion molecules such as cadherins and link them to different cytoskeletal proteins depending on the type of cell junction. At the...
TGF - β Signaling Pathway
What is Cell Signaling?

